Clinical Trial Detail

NCT ID NCT03941782
Title Compassionate Use of BYL 719 Alpelisib
Recruitment Available
Gender both
Phase Phase 0
Variant Requirements Yes
Sponsors New Mexico Cancer Care Alliance
Indications

lymphangioma

Therapies

Alpelisib

Age Groups: adult senior

Additional content available in CKB BOOST